INNOVATE Corp. Announces Extension of Rights Offering Subscription Period

Rhea-AI Summary

INNOVATE Corp. extends subscription period for rights offering, allowing stockholders and noteholders more time to participate. The offering is pursuant to an effective shelf registration statement and prospectus supplement filed with the SEC. The extension aims to provide eligible holders with additional time to subscribe.

NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today that its Board of Directors has extended the subscription period for its rights offering to 5:00 p.m. Eastern Time on April 9, 2024, in order to allow stockholders and noteholders who are entitled to participate in the rights offering (holders of record of the Company’s common stock, Series A-3 Preferred Stock, Series A-4 Preferred Stock and 2026 Convertible Notes as of 5:00 p.m. Eastern Time on March 6, 2024) additional time to participate.

The rights offering is being made pursuant to INNOVATE’s effective shelf registration statement on Form S-3, filed with the SEC on September 29, 2023 and declared effective on October 6, 2023, and a prospectus supplement containing the detailed terms of the rights offering filed with the SEC on March 8, 2024. This press release shall not constitute an offer to sell or a solicitation of an offer to buy any securities (including without limitation the preferred stock issued and sold in the concurrent private placement), nor shall there be any offer, solicitation or sale of the securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful under the securities laws of such state or jurisdiction. The rights offering was made only by means of a prospectus and a related prospectus supplement, copies of which were distributed to all eligible rights holders as of the rights offering record date and may also be obtained free of charge at the website maintained by the SEC at www.sec.gov or by contacting the information agent for the rights offering.

About INNOVATE

INNOVATE Corp. is a portfolio of best-in-class assets in three key areas of the new economy – Infrastructure, Life Sciences and Spectrum. Dedicated to stakeholder capitalism, INNOVATE employs approximately 4,000 people across its subsidiaries. For more information, please visit: www.INNOVATECorp.com.

Cautionary Statement Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release contains, and certain oral statements made by our representatives from time to time may contain, forward-looking statements regarding the rights offering and concurrent private placement, including, among others, statements related to the use of proceeds from the rights offering and other terms of the rights offering, all of which involve risks, assumptions and uncertainties, many of which are outside of the Company's control, and are subject to change. All forward-looking statements speak only as of the date made, and unless legally required, INNOVATE undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Solebury Strategic Communications
Anthony Rozmus
ir@innovatecorp.com
(212) 235-2691

FAQ

What is the ticker symbol for INNOVATE Corp.?

The ticker symbol for INNOVATE Corp. is VATE.

When is the extended subscription period for the rights offering scheduled to end?

The extended subscription period for the rights offering is scheduled to end at 5:00 p.m. Eastern Time on April 9, 2024.

What type of securities are eligible for participation in the rights offering?

Holders of record of the Company’s common stock, Series A-3 Preferred Stock, Series A-4 Preferred Stock, and 2026 Convertible Notes as of March 6, 2024, are eligible to participate in the rights offering.

How was the rights offering made?

The rights offering was made pursuant to INNOVATE’s effective shelf registration statement on Form S-3 filed with the SEC and a prospectus supplement containing detailed terms filed on March 8, 2024.